CONSULTING AGREEMENTConsulting Agreement • November 24th, 2020 • Brickell Biotech, Inc. • Biological products, (no disgnostic substances) • Delaware
This Consulting Agreement (the “Agreement”) is made effective as of December 1, 2020 (the “Effective Date”), by and between Brickell Biotech, Inc., a Delaware corporation, with its principal place of business being 5777 Central Avenue, Suite 102, Boulder, CO 80301 (the “Company”) and Danforth Advisors, LLC, a Massachusetts limited liability corporation, with its principal place of business being 91 Middle Road, Southborough, MA 01772 (“Danforth”). The Company and Danforth are herein sometimes referred to individually as a “Party” and collectively as the “Parties.”
SEPARATION AGREEMENT AND RELEASE OF CLAIMSSeparation Agreement and Release of Claims • November 24th, 2020 • Brickell Biotech, Inc. • Biological products, (no disgnostic substances) • Colorado
This Separation Agreement and Release of Claims ( “Agreement”) is entered into by and between Brickell Biotech, Inc. (the “Company”), and R. Michael Carruthers (“Consultant”) (individually, a “Party”; together, the “Parties”) and will become effective on November 30, 2020 (the “Effective Date”).
